• Journal of Pharmaceutical Investigation
• /
• 제30권4호
• /
• pp.279-282
• /
• 2000

Simple and precise high-performance liquid chromatographic (HPLC) assay was developed and validated for the determination of a HMG-CoA reductase inhibitor, $lovastatin^{TM}$ and its active metabolite (mevinolinic acid) in human plasma. The method involved solid phase extraction of mevinolinic acid and internal standard using Sep-Pak Cartridge. Samples were analyzed by reversed-phase HPLC using $Capcell-Pak\;C_{18}$ column with ultraviolet detection at 238 nm. The quantitation limit of mevinolinic acid was 2 ng/ml and the calibration curve was linear over the range of 2-50 ng/ml $(r^2>0.999)$ with human plasma. The analyses of quality control samples indicated that the normal values could be predicted with an accuracy >97%. The intra- and inter-day coefficients of variation for the analyses were <10%. The average recoveries were similar (79%) for mevinolinic acid and methylmevinolinic acid. The method described has been successfully applied to the quantification of mevinolinic acid in about 1,000 human plasma samples over six-month period.

• 한국식품과학회지
• /
• 제38권2호
• /
• pp.256-261
• /
• 2006

20여종의 Monascus속의 균주로 부터 mevinolin의 생산능이 우수하면서도 곰팡이 독소성분 citrinin을 생산하지 않는 우량균주를 선발하였으며, 콩시료에 대한 고상발효를 최적화하기 위한 영양배지의 조성물이 검토되었다. 선발된 M. pilosus IFO 480으로 발효시킨 홍국콩 발효물에 함유된 mevinolin의 주요 화합물은, 약리학적 활성형(drug)의 mevinolinic acid 밝혀졌다(91.8%). 따라서 홍국 발효콩은 생체활성형의 항 콜레스테롤 성분을 최대 0.22% 까지 함유하는, 안전한 건강 기능성식품 소재로서의 활용가능성이 높은 것으로 평가할 수 있다.